Arcus Biosciences, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26

Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory

0 of 8≥ implied

avg implied: ±16.2%
avg realized: ±2.2%

Nov 6 '24±15.2%▲+4.64%×0.30

Feb 25 '25±11.1%▼−0.98%×0.09

May 6 '25±21.1%▼−1.35%×0.06

Aug 6 '25±15.4%▼−2.21%×0.14

Oct 28 '25±17.7%▲+2.06%×0.12

Q1 FY26±19.9%▼−3.60%×0.18

May 5 '26±18.0%▼−0.23%×0.01

Q2 FY26±11.2%▲+2.27%×0.20

quarterimplied−25%0+25%realized×

Q2 FY26±11.2%▲+2.27%×0.20

May '26±18.0%▼−0.23%×0.01

Q1 FY26±19.9%▼−3.60%×0.18

Oct '25±17.7%▲+2.06%×0.12

Aug '25±15.4%▼−2.21%×0.14

May '25±21.1%▼−1.35%×0.06

2 older reports

Feb '25±11.1%▼−0.98%×0.09

Nov '24±15.2%▲+4.64%×0.30

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

232managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+7.02%change in shares held by the ten largest reporting managers last quarter13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history

9 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

RCUS report session

Suppliers 1

GILDGilead×0.11

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 28impliedImplied move: ±15.5% into Nov 4 earnings (Oct 28 close).Source

Oct 13impliedImplied move: ±23.9% into Oct 27 earnings (Oct 13 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.